{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:46:56Z","timestamp":1771026416898,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T00:00:00Z","timestamp":1640822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jfma.2021.12.028","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T04:19:34Z","timestamp":1641356374000},"page":"1003-1007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review"],"prefix":"10.1016","volume":"121","author":[{"given":"Chii-Shyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2642-5114","authenticated-orcid":false,"given":"Hsuan-Hsiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2021.12.028_bib1","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/jdv.12942","article-title":"Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature","volume":"30","author":"Drago","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jfma.2021.12.028_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jcma.2011.04.010","article-title":"Pityriasis rosea following influenza (H1N1) vaccination","volume":"74","author":"Chen","year":"2011","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.jfma.2021.12.028_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000362640","article-title":"An atypical case of pityriasis rosea gigantea after influenza vaccination","volume":"6","author":"Papakostas","year":"2014","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.jfma.2021.12.028_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jdcr.2020.10.035","article-title":"Pityriasis rosea in otherwise asymptomatic confirmed COVID-19\u2013positive patients: a report of 2 cases","volume":"7","author":"Johansen","year":"2021","journal-title":"JAAD Case Rep"},{"issue":"6","key":"10.1016\/j.jfma.2021.12.028_bib5","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/bjd.19833","article-title":"SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19","volume":"184","author":"Welsh","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jfma.2021.12.028_bib6","article-title":"Cutaneous reactions after SARS-COV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases","author":"Catal\u00e0","year":"2021","journal-title":"BJD"},{"key":"10.1016\/j.jfma.2021.12.028_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases","volume":"85","author":"McMahon","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jfma.2021.12.028_bib8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jdcr.2018.04.002","article-title":"Pityriasis rosea and pityriasis rosea-like eruptions: how to distinguish them?","volume":"4","author":"Drago","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jfma.2021.12.028_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/jocd.14372","article-title":"Pityriasis rosea following SARS-CoV-2 vaccination: a case series","volume":"20","author":"Temiz","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jfma.2021.12.028_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15040","article-title":"Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male","volume":"34","author":"Adya","year":"2021","journal-title":"Dermatol Ther"},{"issue":"8","key":"10.1016\/j.jfma.2021.12.028_bib11","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1111\/jdv.17316","article-title":"Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report","volume":"35","author":"Akda\u015f","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.jfma.2021.12.028_bib12","doi-asserted-by":"crossref","first-page":"e546","DOI":"10.1111\/jdv.17342","article-title":"Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine","volume":"35","author":"Cyrenne","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jfma.2021.12.028_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.17498","article-title":"Pityriasis rosea developing after COVID-19 vaccination","volume":"35","author":"Marcantonio-Santa Cruz","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jfma.2021.12.028_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.17301","article-title":"Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance","volume":"35","author":"Busto-Leis","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jfma.2021.12.028_bib15","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1111\/bjd.20143","article-title":"Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination","volume":"185","author":"Carballido V\u00e1zquez","year":"2021","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.jfma.2021.12.028_bib16","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/ijd.15700","article-title":"Pityriasis rosea after mRNA COVID-19 vaccination","volume":"60","author":"Abdullah","year":"2021","journal-title":"Int J Dermatol"},{"issue":"25","key":"10.1016\/j.jfma.2021.12.028_bib17","first-page":"431","article-title":"Pityriasis rosea as a possible complication of vaccination against COVID-19","volume":"118","author":"Dormann","year":"2021","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jfma.2021.12.028_bib18","article-title":"Two cases of pityriasis rosea after the injection of coronavirus disease 2019 vaccine","volume":"36","author":"Huang","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jfma.2021.12.028_bib19","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1111\/jdv.16579","article-title":"Pityriasis rosea as a cutaneous manifestation of COVID-19 infection","volume":"34","author":"Ehsani","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jfma.2021.12.028_bib20","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/jmv.26549","article-title":"Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19","volume":"93","author":"Drago","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.jfma.2021.12.028_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13878","article-title":"SARS-CoV-2 as possible inducer of viral reactivations","volume":"33","author":"Ciccarese","year":"2020","journal-title":"Dermatol Ther"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664621005957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664621005957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:48:05Z","timestamp":1760539685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664621005957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0929664621005957"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2021.12.028","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2021.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}